Nutlin - Wikipedia
Frontiers | Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments | Oncology
The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276 | Cellular & Molecular Biology Letters | Full Text
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma | British Journal of Cancer
Frontiers | Clinical Overview of MDM2/X-Targeted Therapies | Oncology
Nutlin-3 | ≥99%(HPLC) | Selleck | Mdm2 antagonist
MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation | PLOS ONE
Identification of MDM2 inhibitor RG7112 from Nutlin-3. (A) Crystal... | Download Scientific Diagram
The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276 | Cellular & Molecular Biology Letters | Full Text
Nutlin-3 | CAS 548472-68-0 | AbMole BioScience | Nutlin-3 Price
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells | Cell Death & Disease
Cancers | Free Full-Text | Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists | HTML
p53 programmes plough on
Nutlin 3 - an overview | ScienceDirect Topics
Nutlin-3 | STEMCELL Technologies
The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276 | Cellular & Molecular Biology Letters | Full Text
Targeted nutlin-3a loaded nanoparticles inhibiting p53–MDM2 interaction: novel strategy for breast cancer therapy | Nanomedicine
The sensitivity to MDM2 antagonists, Nutlin-3 and RG7388, and rucaparib... | Download Scientific Diagram
MDM2 antagonists as a novel treatment option for acute myeloid leukemi | OTT
Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3 | Circulation Research
The hydrophobically-tagged MDM2–p53 interaction inhibitor Nutlin-3a-HT is more potent against tumor cells than Nutlin-3a - Chemical Communications (RSC Publishing) DOI:10.1039/C9CC07795B
Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin- 3 in acute myeloid leukemia | Leukemia
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
